Pharmacy

Senate Finance Committee Chairman Sen. Chuck Grassley, R-Iowa, is questioning the recent move by Cigna and Express Scripts to cap out-of-pocket insulin costs for some patients at $25 per month.

After Scott Gottlieb, MD, steps down as commissioner of the FDA April 5, he will head back to the American Enterprise Institute to tackle the rising cost of prescription drugs, according to The Washington Post.

CVS Health and Walgreens Boots Alliance are pivoting from their normal businesses in an effort to shore up finances and outrun the challenges facing retailers and healthcare organizations nationwide.

CVS Health is now offering same-day prescription delivery services at 6,000 locations nationwide.

Pharmaceutical Associates, a drugmaker based in Greenville, S.C., raised the price of its generic version of Prozac by 568 percent, according to The Financial Times.

Below are 13 legal actions involving the drug supply chain, including pharmaceutical companies, PBMs and distributors, reported by Becker's Hospital Review in the last month.

Several drugs are slated to make their debuts in 2019, but only seven are projected to achieve blockbuster status within four years, according to a new report from analytic firm Cortellis.

A California biotech claims that the controversial billionaire biotech entrepreneur Patrick Soon-Shiong, MD, orchestrated a "catch and kill" scheme to stop development of an experimental cancer drug that may have saved the U.S. healthcare system more than $1 billion, according…

Three drugmakers — Eli Lilly, Novo Nordisk and Sanofi — will testify at the House Energy and Commerce committee hearing on insulin prices April 10, according to The Hill.

Cigna and Express Scripts launched a program that limits members' out-of-pocket insulin costs to $25 for a 30-day supply, the companies said April 3.